Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JUSTIN P FAVARO

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1053365320
CMS profile
1303344
Location
CHARLOTTE, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$3,709.64

158 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,612.39 156
Education $84.75 1
Travel and Lodging $12.50 1

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $233.57 11
ASD Specialty Healthcare, LLC $223.95 3
CTI BioPharma Corp. $172.97 2
AstraZeneca Pharmaceuticals LP $163.89 8
Amgen Inc. $160.78 8
PFIZER INC. $150.35 8
Janssen Biotech, Inc. $142.97 7
Genentech USA, Inc. $129.23 7
AngioDynamics, Inc. $129.14 2
E.R. Squibb & Sons, L.L.C. $111.19 6
Celgene Corporation $104.05 5
Daiichi Sankyo Inc. $101.19 4
Foundation Medicine, Inc. $95.37 4
Eisai Inc. $89.07 4
Seagen Inc. $88.27 4
SANOFI-AVENTIS U.S. LLC $84.75 1
IntrinsiQ Specialty Solutions, Inc. $78.04 1
Lilly USA, LLC $75.30 4
Merck Sharp & Dohme LLC $72.44 3
GENZYME CORPORATION $70.97 3
EMD Serono, Inc. $67.81 3
GlaxoSmithKline, LLC. $67.60 4
Alexion Pharmaceuticals, Inc. $61.94 3
MorphoSys, US Inc. $58.39 3
Takeda Pharmaceuticals U.S.A., Inc. $54.96 2
Bayer Healthcare Pharmaceuticals Inc. $54.35 2
BeiGene USA, Inc. $52.78 3
Novocure Inc. $49.76 2
Incyte Corporation $47.36 2
Stemline Therapeutics Inc. $46.07 2
ABBVIE INC. $44.61 2
ADC Therapeutics America, Inc. $39.95 2
SERVIER PHARMACEUTICALS LLC $39.84 2
Spectrum Pharmaceuticals Inc. $38.80 2
Genentech, Inc. $38.48 2
ARRAY BIOPHARMA INC $36.54 3
Gilead Sciences, Inc. $35.04 2
Exelixis Inc. $33.33 2
Kyowa Kirin, Inc. $31.51 2
Astellas Pharma US Inc $29.68 2
Regeneron Healthcare Solutions, Inc. $28.05 1
RECORDATI_RARE_DISEASES_INC. $26.09 1
Progenics Pharmaceuticals, Inc. $23.51 1
JAZZ PHARMACEUTICALS INC. $23.28 1
Organon LLC $22.92 1
Agios Pharmaceuticals, Inc. $20.78 1
Alnylam Pharmaceuticals Inc. $19.39 1
Janssen Pharmaceuticals, Inc $19.15 1
Boehringer Ingelheim Pharmaceuticals, Inc. $18.09 1
Mirati Therapeutics, Inc. $17.37 1
Octapharma USA, Inc. $17.09 1
Puma Biotechnology, Inc. $14.75 1
Pharmacosmos Therapeutics Inc. $13.96 1
Pharmacyclics LLC, An AbbVie Company $13.25 1
Shield Therapeutics Inc $13.18 1
Rigel Pharmaceuticals, Inc. $12.49 1

Page 3 of 4; records 101–150 of 158 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JUSTIN P FAVARO

NPI 1053365320 · CMS profile ID 1303344

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

CHARLOTTE, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 158 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1053365320?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JUSTIN P FAVARO, NPI 1053365320, CMS profile ID 1303344. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 158 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1053365320?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). JUSTIN P FAVARO, NPI 1053365320, CMS profile ID 1303344. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 158 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1053365320?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
JUSTIN P FAVARO, NPI 1053365320, CMS profile ID 1303344, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 158 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1053365320?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

158 matching records · $3,709.64 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 158 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 158.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Genentech USA, Inc. $17.7504/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040420409 CMS
Amgen Inc. $14.5104/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019982863 CMS
Bayer Healthcare Pharmaceuticals Inc. $28.7304/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000526191 CMS
PFIZER INC. $25.5004/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049175815 CMS
Eisai Inc. $24.0503/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023317447 CMS
Alexion Pharmaceuticals, Inc. $19.9903/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017030001 CMS
ASD Specialty Healthcare, LLC $68.2803/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052998857 CMS
IntrinsiQ Specialty Solutions, Inc. $78.0403/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053000687 CMS
ASD Specialty Healthcare, LLC $75.7203/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052998889 CMS
ASD Specialty Healthcare, LLC $79.9503/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052998737 CMS
E.R. Squibb & Sons, L.L.C. $17.4303/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015351239 CMS
PFIZER INC. $21.9803/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049473181 CMS
PFIZER INC. $11.9503/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049413955 CMS
Lilly USA, LLC $16.2603/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031895485 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.6103/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055385729 CMS
GENZYME CORPORATION $25.0903/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049987695 CMS
SANOFI-AVENTIS U.S. LLC $84.7503/15/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049987639 CMS
E.R. Squibb & Sons, L.L.C. $20.3903/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015351199 CMS
Stemline Therapeutics Inc. $21.4803/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040029667 CMS
Genentech, Inc. $24.7703/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040420385 CMS
Genentech, Inc. $13.7103/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040420391 CMS
GlaxoSmithKline, LLC. $16.9103/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002774593 CMS
EMD Serono, Inc. $16.1403/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032301107 CMS
Amgen Inc. $19.1503/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020612105 CMS
Celgene Corporation $18.1203/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015351207 CMS
Novartis Pharmaceuticals Corporation $12.6203/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991686553 CMS
GENZYME CORPORATION $24.3503/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049987659 CMS
ABBVIE INC. $26.3902/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997235499 CMS
BeiGene USA, Inc. $18.0702/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051191499 CMS
Kyowa Kirin, Inc. $14.3202/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1027003371 CMS
Stemline Therapeutics Inc. $24.5902/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040029673 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.0902/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996628779 CMS
GlaxoSmithKline, LLC. $15.9002/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002774605 CMS
Pharmacyclics LLC, An AbbVie Company $13.2502/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998285399 CMS
AngioDynamics, Inc. $12.5002/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025283745 CMS
AngioDynamics, Inc. $116.6402/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025283747 CMS
Incyte Corporation $25.7002/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044488063 CMS
EMD Serono, Inc. $29.6902/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032329713 CMS
E.R. Squibb & Sons, L.L.C. $20.6102/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015351215 CMS
Daiichi Sankyo Inc. $23.4502/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006398457 CMS
Seagen Inc. $27.4502/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995676227 CMS
Amgen Inc. $17.0002/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019982861 CMS
SERVIER PHARMACEUTICALS LLC $21.6302/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055089835 CMS
Novocure Inc. $28.2701/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021072509 CMS
E.R. Squibb & Sons, L.L.C. $18.6901/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015351143 CMS
ARRAY BIOPHARMA INC $18.2201/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049143239 CMS
Regeneron Healthcare Solutions, Inc. $28.0501/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999168761 CMS
Spectrum Pharmaceuticals Inc. $14.8001/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059886235 CMS
Puma Biotechnology, Inc. $14.7501/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059058855 CMS
Genentech USA, Inc. $22.1801/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040420403 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,569.15 125
PY2020 $2,085.28 26
PY2021 $5,036.92 52
PY2022 $5,267.46 135
PY2023 $3,709.64 158
PY2024 $8,084.02 130
PY2025 $5,825.14 111

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $10,669.71 6
PY2024 Principal investigator $81,306.50 70
PY2023 Principal investigator $172,378.46 75
PY2022 Principal investigator $143,742.07 59
PY2021 Principal investigator $139,700.95 55
PY2020 Principal investigator $143,075.60 71
PY2019 Principal investigator $231,106.80 86

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $544.71 10/23/2025 Non-covered Recipient Entity
DJL CLINICAL RESEARCH PLLC
CEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY No dispute reported 06/30/2026 1184252880
Principal investigator 1 GlaxoSmithKline, LLC. $1,500.00 05/15/2025 Non-covered Recipient Entity
DJL CLINICAL RESEARCH PLLC
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER S No dispute reported 06/30/2026 1192173089
Principal investigator 1 GlaxoSmithKline, LLC. $1,000.00 05/15/2025 Non-covered Recipient Entity
DJL CLINICAL RESEARCH PLLC
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER S No dispute reported 06/30/2026 1192173094
Principal investigator 1 GlaxoSmithKline, LLC. $2,000.00 05/15/2025 Non-covered Recipient Entity
DJL CLINICAL RESEARCH PLLC
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER S No dispute reported 06/30/2026 1192173103
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,125.00 02/13/2025 Non-covered Recipient Entity
DJL CLINICAL RESEARCH PLLC
CEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY No dispute reported 06/30/2026 1184153982
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $3,500.00 01/17/2025 Non-covered Recipient Entity
DJL CLINICAL RESEARCH
A Phase 2 Study of Cemiplimab (Anti-PD-1 Antibody) in Combination With BNT116 (FixVac Lung) Versus Cemiplimab Monotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Tumors Expressing PD-L1 =50% No dispute reported 06/30/2026 1184148125